Bizarre Patents
A forehead support apparatus for resting a standing users forehead against a wall above a bathroom commode or urinal or beneath a showerhead.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20080289058 | Targeted delivery of glycine receptors to excitable cells The invention provides a method of modulating electrophysiological activity of an excitable cell. The method involves causing exogenous expression of a glycine receptor (GlyR) protein in an excitable cell of a subject. Thereafter, the excitable cell is exposed to an all... | 11/20/2008 |
| 20080281248 | REMOVAL OF CONTRAST AGENTS FROM BLOOD The invention provides a system and a method for removal of contrast from blood. In one aspect, the invention provides a catheter for removal of contrast from the veins that drain the cerebral circulation. In a second aspect, the invention provides a method for removing... | 11/13/2008 |
| 20080280834 | Compounds and methods for inhibiting apoptosis The invention provides compounds, compositions, and methods for inhibiting apoptosis and for the treatment of conditions related thereto.... | 11/13/2008 |
| 20080262483 | METHOD FOR REMOVING PERMANENT TISSUE MARKINGS A method of removing markings, such as a tattoos, from the tissue of a subject that includes steps of generating one or more shock wave pulses external to the subject's body and focusing the one or more shock wave pulses within one or more portions of the tissue, each o... | 10/23/2008 |
| 20080250058 | PROCESS DATA WAREHOUSE Systems and/or methods are presented that can efficiently analyze and summarize large collections of data. A summarization component can employ mapping rules to map received data into specified states and observations of interest, which can be utilized to facilitate cre... | 10/09/2008 |
| 20080248574 | ANTAGONISTS OF THE INTERACTION OF MELANOMA INHIBITORY ACTIVITY (MIA) AND P66SHC The invention provides polypeptides, nucleic acids encoding the polypeptides, optionally in a vector, and their use in methods to disrupt the interaction between p66shc and Melanoma Inhibitory Activity (MIA) in a cell and to sensitize a cell to oxidative stress.... | 10/09/2008 |
| 20080223936 | SECURITY FOR BLISTER PACKS Various RFID based blister pack embodiments are provided for improving the ability to detect and prevent tampering and counterfeiting of blister packs and/or facilitating the chain of custody tracking of blister packs during manufacture. Some embodiments employ an RFID ... | 09/18/2008 |
| 20080206280 | VACCINE FOR ACTIVATING HELPER FUNCTION OF CD8+ TCELLS The invention provides compositions and methods for treating or preventing a target disease in a mammal by induction of memory T cells. The methods comprise (1) administering a sensitizing composition comprising a non-target antigen to a patient; and (2) administering a... | 08/28/2008 |
| 20080194737 | POLYMER AND METHOD FOR USING THE POLYMER FOR SOLUBILIZING NANOTUBES A new, non-wrapping approach to solubilize nanotubes, such as carbon nanotubes, in organic and inorganic solvents is provided. In accordance with certain embodiments, carbon nanotube surfaces are functionalized in a non-wrapping fashion by functional conjugated polymers... | 08/14/2008 |
| 20080187482 | POLYMER AND METHOD FOR USING THE POLYMER FOR NONCOVALENTLY FUNCTIONALIZING NANOTUBES A new, non-wrapping approach to functionalizing nanotubes, such as carbon nanotubes, in organic and inorganic solvents is provided. In accordance with certain embodiments, carbon nanotube surfaces are functionalized in a non-wrapping fashion by functional conjugated pol... | 08/07/2008 |
| 20080174406 | TRANSPONDER SYSTEMS A transponder system that includes at least one transponder apparatus that does not have an antenna and a reader device having a touch probe having one or more probe contacts for enabling the reader device to communicate with the transponder apparatus through a temporar... | 07/24/2008 |
| 20080171021 | PHARMACEUTICAL USE OF NITRIC OXIDE, HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION The present invention relates to the treatment of disorders using nitric oxide (NO), heme oxygenase-1 (HO-1) and heme degradation products such as carbon monoxide (CO), biliverdin, bilirubin and iron.... | 07/17/2008 |
| 20080169928 | TRANSPONDER NETWORKS AND TRANSPONDER SYSTEMS EMPLOYING A TOUCH PROBE READER DEVICE Transponder networks and transponder systems are provided which help to overcome the issues presented to transponders systems by FCC power limitations. One embodiment provides a transponder network that includes a plurality of RFID straps in order to increase the amount... | 07/17/2008 |
| 20080090258 | Method and composition for diagnosing endometrial cancer The present invention is related to methods and reagents for a multifactorial assay for the rapid, early detection of cancer and, more particularly, is related to a multimarker serological diagnostic test for early detection of endometrial cancer. ... | 04/17/2008 |
| 20080085879 | METHODS OF TREATING ESTROGEN-RESPONSIVE CONDITIONS BY ORPHAN NUCLEAR RECEPTOR ACTIVATION The invention provides a method of treating an estrogen responsive condition comprising administration of an agonist of an orphan nuclear receptor, wherein activation of the orphan nuclear receptor inhibits estrogen activity. The invention also provides a method of redu... | 04/10/2008 |
| 20080004207 | USE OF HMGB1 FOR PROTECTION AGAINST ISCHEMIA REPERFUSION INJURY Methods and compositions are disclosed for protecting an organ or tissue from inflammation and organ injury following ischemia, reperfusion, and trauma through the administration of an HMGB1 protein within a time period sufficient to protect the organ or tissue f... | 01/03/2008 |
| 20080003304 | COMBINATION CHEMOTHERAPY This invention relates to combination chemotherapy, particularly involving vitamin D or a derivative thereof hi one aspect, the invention provides a method of killing a cell by first administering to the cell vitamin D (or a derivative) and subsequently administering to... | 01/03/2008 |
| 20070264239 | ISOLATION OF PERICYTES In one embodiment, the invention provides a pericyte having a marker pattern comprising CD146+, CD34−, and CD45−, wherein said pericyte is substantially isolated from cells that are CD146− or CD31+ or CD34+ or CD45+ or CD56+ or NG2− or CD133−. The invention al... | 11/15/2007 |
| 20070238137 | CONSTITUTIVELY RESISTANT CANCER STEM CELLS IN DIAGNOSIS The invention provides a method of identifying circulating clonogenic cancerous cells, specifically multiply-drug resistant (MDR) cancer stem cells. ... | 10/11/2007 |
| 20070218451 | PEROXISOME-PROLIFERATOR ACTIVATED RECEPTOR-ALPHA AGONISTS FOR ORGAN PRESERVATION Methods and compositions for reducing, preventing or reversing organ damage and/or enhancing organ preservation by administration of a peroxisome-proliferator activated receptor-alpha (PPARα) agonist to the organ.... | 09/20/2007 |
| 20070207464 | Method for diagnosing renal diseases or predispositions The invention provides a method of diagnosing a disease or a predisposition to contract a disease by assaying for mutations of uromodulin (UMOD) within a test subject or patient. The presence of a mutation in the UMOD supports a diagnosis of a disease or a predispositio... | 09/06/2007 |
| 20070207124 | Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain The invention provides a vector, preferably a herpes simplex virus (HSV) vector, comprising a polynucleotide sequence encoding a glutamic acid decarboxylase (GAD) protein. The invention also provides a stock of such vectors and a pharmaceutical composition comprising su... | 09/06/2007 |
| 20070184522 | Cell death modulation via antagonists of Fasl and Fas activation The invention provides a polypeptide that attenuates the activation of Fas, TNFR1, or both. The polypeptide can be used to treat conditions associated with dysregulation of the cell death or inflammatory pathway and can be formulated into pharmaceutical compositions for... | 08/09/2007 |
| 20070178069 | HERPES SIMPLEX VIRUS VECTOR The invention provides a herpes simplex virus vector comprising deletions in ICP4, ICP27, and UL55. ... | 08/02/2007 |
| 20070176752 | METHODS AND APPARATUS FOR REDUCING POWER CONSUMPTION OF AN ACTIVE TRANSPONDER A power management method for a transponder having a plurality of circuits including at least a first circuit having a first active state requiring at least a first power level, and a second circuit having a second active state requiring at least a second power level gr... | 08/02/2007 |
| 20070173214 | WIRELESS AUTONOMOUS DEVICE SYSTEM A method of powering a wireless autonomous device having energy harvesting circuitry, on-board electronic circuitry, and RF transmitter circuitry using an RF transmitting profile that includes a plurality of RF pulses. That same profile may also be used to simultaneousl... | 07/26/2007 |
| 20070167375 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response The invention provides a peptide derived from the interleukin-13 receptor α2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary u... | 07/19/2007 |
| 20070166720 | Small interfering RNA libraries and methods of synthesis and use In one aspect, the invention provides a random or semirandom siRNA (encoding) library. Another aspect of the invention pertains to methods for construction of random or semirandom siRNA (encoding) libraries. Another aspect of the invention is vector systems for use in c... | 07/19/2007 |
| 20070153561 | MULTIPLE ANTENNA ENERGY HARVESTING Energy harvesting circuits and associated methods are provided that employ multiple antennas to optimize the amount of energy that is harvested while at the same time making efficient use of tag space. In some embodiments, matching networks are chosen in a manner that o... | 07/05/2007 |
| 20070122415 | Compound and method for suppressing retroviral replication In one aspect, the invention provides an antiretroviral peptide that suppresses replication of a retrovirus and the use thereof to inhibit retroviral replication within cells infected with a retrovirus. The method can be used in vivo to treat retroviral infection in hum... | 05/31/2007 |
| 20070042405 | Enhanced diagnostic multimarker serological profiling The present invention is related to methods of early diagnosis of ovarian cancer in a patient by determining serum levels of blood markers using a novel LabMAP™ technology (Luminex Corp., Austin, Tex.), which allows for simultaneous measurement of the blood markers in... | 02/22/2007 |
| 20070012773 | Method of making an electronic device using an electrically conductive polymer, and associated products Described are methods of making an electronic device including an electronic component, such as an IC chip, connected to conducting traces provided on a substrate by depositing an electrically conductive polymer deposited onto the substrate. The electronic component may... | 01/18/2007 |
| 20060294610 | Alpha1-3 galactosyltransferase gene and promoter The present invention provides a recombinant expression cassette comprising an α1-3 galactosyltransferase promoter operably linked to a polynucleotide for expression. The invention also provides a recombinant mutating cassette comprising a region of homology to an α1-... | 12/28/2006 |
| 20060281070 | Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy The invention provides an expression cassette comprising a DNA sequence encoding amino acids 1-99 of human preproenkephalin, a DNA sequence encoding a precursor of a carboxy-amidated peptide flanked by dibasic cleavage sites and optionally a DNA sequence encoding a mark... | 12/14/2006 |
| 20060275812 | Assay for agonists and antagonists of ion channels and for regulators of genetic expression The invention provides an assay for agonists and antagonists of ion channels and for regulators of genetic expression. ... | 12/07/2006 |
| 20060275752 | Multiparameteric method for assessing immune system status The invention provides a multiparametric method of assessing the reaction of a patient's immune system to a test subject. The invention compares a patient sample reacted with a test sample and a third party sample and combines the assessments of the multiple parameters ... | 12/07/2006 |
| 20060267200 | Method of making an electronic device using an electrically conductive polymer, and associated products Described are methods of making an electronic device, such as an RFID tag, including fabricating an antenna by depositing an electrically conductive polymer onto a substrate. The electrically conductive polymer is electrically connected to an electronic component, such ... | 11/30/2006 |
| 20060263334 | Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen The invention provides an isolated nucleic acid encoding a receptor, other than an immunoglobulin, wherein the receptor binds to a MUC1 tumor antigen independently of an major histocompatibility complex (MHC). The invention provides a method of activating a signaling pa... | 11/23/2006 |
| 20060200238 | Posterior oblique lumbar arthrodesis Instruments and methods for spinal stabilization are disclosed. In preferred embodiments, the invention provides greater stabilization of vertebral bodies through methods including combinations of external fixation systems and intervertebral implants to provide greater ... | 09/07/2006 |
| 20060178306 | Modulation of the neuroendoctrine system as a therapy for motor neuron disease The invention provides a method for treating amyotrophic lateral sclerosis (ALS) in a subject. The method comprises administering to the nervous system of the subject a composition comprising a thyroxine protein or a therapeutic fragment or pharmacologic mimic thereof a... | 08/10/2006 |
